Royalty Pharma may offer $6.6 billion bid for Elan

[riky]

Royalty Pharma may offer $6.6 billion bid for Elan

<p><a href="http://news.yahoo.com/royalty-pharma-proposes-6-6-billion-bid-elan-104642175--finance.html"><img src="http://l2.yimg.com/bt/api/res/1.2/2r2.8mo6n3uev4Zxufr4fg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-02-25T104854Z_1_CBRE91O0U1L00_RTROPTP_2_HEALTH-SUMMIT.JPG" width="130" height="86" alt="Kelly Martin, President and CEO of Elan, speaks at the Reuters Health Summit in New York" align="left" title="Kelly Martin, President and CEO of Elan, speaks at the Reuters Health Summit in New York" border="0" /></a>DUBLIN (Reuters) - U.S. investment firm Royalty Pharma has made a $6.6 billion approach to Irish drugmaker Elan, targeting royalty rights for multiple sclerosis treatment Tysabri worth hundreds of millions of dollars annually. Elan said earlier this month it was to sell its 50 percent interest in Tysabri for $3.25 billion plus future royalty payments to U.S. partner Biogen Idec, and then reinvent itself with a series of acquisitions. Those royalty payments on future Tysabri sales, which rose 8 percent to $1.63 billion in 2012, will be 12 percent for the first year and 18 percent thereafter. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login